norgestrel has been researched along with Menopause in 75 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 62 (82.67) | 18.7374 |
1990's | 12 (16.00) | 18.2507 |
2000's | 1 (1.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morsman, J; Varma, TR | 1 |
Varma, TR | 2 |
Moore, B; Paterson, ME; Sturdee, DW; Whitehead, TP | 1 |
King, RJ; Townsend, PT; Whitehead, MI | 1 |
King, RJ; Lane, G; Pryse-Davies, J; Ryder, T; Siddle, N; Townsend, PT; Whitehead, MI | 1 |
King, RJ; Minardi, J; Siddle, NC; Townsend, PT; Whitehead, MI; Young, O | 1 |
Punnonen, R; Rauramo, L; Vilska, S | 2 |
Fåhraeus, L; Larsson-Cohn, U; Wallentin, L | 1 |
Farish, E; Fletcher, CD; Hart, DM; Lindsay, R; Sharpe, GL | 1 |
Lammintausta, R; Punnonen, R; Viinamäki, O | 1 |
Lähteenmäki, P; Sipinen, S | 1 |
Kuusi, T; Nikkilä, EA; Sipinen, S; Tikkanen, MJ | 1 |
Osborn, RA; Wren, BG | 1 |
Elamsson, K; Englund, DE; Johansson, ED; Odlind, V; Victor, A | 1 |
Burrows, GD; Dennerstein, L | 1 |
Craft, IL; Mugglestone, CJ; Swinhoe, JR | 1 |
King, RJ; Lane, G; Pryse-Davies, J; Ryder, T; Siddle, NC; Townsend, PT; Whitehead, MI | 1 |
Burrows, GD; Dennerstein, L; Fotherby, K; Laby, B; Wood, C | 1 |
King, RJ; Pryse-Davies, J; Ryder, TA; Townsend, PT; Whitehead, MI | 1 |
Hirvonen, E; Mälkönen, M; Manninen, V | 1 |
Huff, MW; Wolfe, BM | 2 |
Crook, D; Godsland, IF; Lees, B; Stevenson, JC; Whitehead, MI | 1 |
Creinin, MD | 1 |
Rozenberg, S | 1 |
Ambrosini, A; Becagli, L; D'Antona, N; Dalla Pria, S | 1 |
Davajan, V; Kawagoe, S; Mishell, DR; Moore, DE; Nakamura, RM | 1 |
Hiroi, M; Kawagoe, S | 1 |
Anderton, KJ; Brooke, LM; Cooke, ID; Lenton, EA; Sexton, L | 1 |
Englund, DE; Johansson, ED | 1 |
Schneider, WH; Spona, J | 1 |
Lageder, H | 1 |
Burrows, GD; Dennerstein, L; Hyman, GJ; Sharpe, K | 1 |
Branch, RA; Halliwell, M; Homeida, M | 1 |
Craft, I; Mugglestone, CJ; Swinhoe, J | 1 |
Knoth, M; Nathan, E; Nilsson, BO | 1 |
Crilly, RG; Marshall, DH; Nordin, BE | 1 |
Christensen, NC; Davidsen, PC; Pedersen, GT; Secher, NJ | 2 |
Irsigler, K; Lageder, H; Matt, K; Schneider, WH; Schubert, H | 1 |
Rademaker, B; Schwarz, F; Thijssen, JH; van Kammen, E | 1 |
Accinelli, G; Cortellardo, G; Santoni, G; Sbernini, R | 1 |
Dagen, MM; Farish, E; Fletcher, CD; Hart, DM | 1 |
Plunkett, ER; Wolfe, BM | 1 |
Makkonen, M; Penttilä, I; Saarikoski, S | 1 |
Anderson, DC; Buckler, HM; Burger, HG; Evans, CA; Mamtora, H | 1 |
Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
LaRosa, JC; Miller, VT; Muesing, RA; Phillips, EA; Stillman, RJ; Stoy, DB | 1 |
Applebaum-Bowden, D; Auerbach, BJ; Case, LD; Colvin, PL; Hazzard, WR | 1 |
Cust, MP; Gangar, KF; Hillard, TC; Lees, B; Stevenson, JC; Whitehead, MI | 1 |
Aedo, AR; Diczfalusy, E; Landgren, BM | 1 |
Beastall, G; Farish, E; Fletcher, CD; Gray, CE; Hart, DM; Lindsay, R | 1 |
Aedo, AR; Diczfalusy, E; Landgren, BM; Le Donne, M | 1 |
Aedo, AR; Diczfalusy, E; Landgren, BM; Sundén, M | 1 |
Endacott, J; Fraser, D; Morton, J; Pryse-Davies, J; Ryder, TA; Whitehead, MI | 1 |
Katsarova, M; Rachev, E; Trepechov, S | 1 |
Allam, BF; Dagen, MM; Farish, E; Fletcher, CD; Hart, DM | 1 |
Fotherby, K | 1 |
King, RJ; Whitehead, MI | 1 |
Hirvonen, E; Kärkkäinen, J; Lipasti, A; Mälkönen, M; Manninen, V; Nuntila, J; Timonen, H | 1 |
Stenman, UH; Vartiainen, E; Widholm, O; Ylöstalo, P | 1 |
Alazzawi, F; Farish, E; Fletcher, CD; Hart, DM; Howie, C; Teo, HT | 1 |
Abdalla, HI; Beastall, G; Fletcher, D; Hart, DM; Hawthorn, JS; Smith, J | 1 |
Fredricsson, B; Hirt, M; Lagrelius, A; Weintraub, L | 1 |
Cajander, S; Holst, J; von Schoultz, B | 1 |
Dooley, M; Fogelman, I; Montgomery, J; Murby, B; Savvas, M; Studd, JW | 1 |
Anagnostopoulos, NI; Papapetrou, PD | 1 |
Garrett, D; Wren, B | 1 |
Johansson, BG; Ottosson, UB; von Schoultz, B | 1 |
Bout, J; Hellema, M; Johannisson, E; Nilsson, L; Patek, E | 1 |
Gambrell, RD | 1 |
Boshell, BR; Fox, OJ; McAdams, GL; Roddam, RF | 1 |
Leyendecker, G; Saxena, BB | 1 |
1 review(s) available for norgestrel and Menopause
Article | Year |
---|---|
Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy.
Topics: Animals; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hormone Replacement Therapy; Humans; Menopause; Norgestrel; Progestins; Risk Factors | 2001 |
21 trial(s) available for norgestrel and Menopause
Article | Year |
---|---|
L-norgestrel and progesterone have different influences on plasma lipoproteins.
Topics: Cholesterol; Contraceptives, Oral, Combined; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Menopause; Middle Aged; Norgestrel; Phospholipids; Progesterone; Triglycerides | 1983 |
Steroid and gonadotropin profiles in menopausal women on three different oral replacement regimens.
Topics: Adult; Clinical Trials as Topic; Drug Administration Schedule; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norethindrone; Norgestrel | 1980 |
Combined estrogen and progestogen for the menopause.
Topics: Climacteric; Clinical Trials as Topic; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norgestrel; Random Allocation | 1980 |
Oral versus transdermal hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Blood Glucose; Bone Density; Cardiovascular Diseases; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin; Lipoproteins; Longitudinal Studies; Menopause; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides; White People | 1993 |
The effects of Premarin and norgestrel on plasma FSH, LH and androstenedione in post-menopausal women.
Topics: Adult; Androstenedione; Castration; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Hysterectomy; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Time Factors | 1978 |
Experimental and clinical data on Cyclabil.
Topics: Adult; Cervix Mucus; Cervix Uteri; Clinical Trials as Topic; Drug Combinations; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Menstruation; Norgestrel; Pregnancy; Progesterone | 1977 |
Carbohydrate metabolism and hormonal replacement therapy: problems and clinical results.
Topics: Alkaline Phosphatase; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Castration; Clinical Trials as Topic; Drug Combinations; Estradiol; Estrogens; Female; Humans; Hysterectomy; Iodine; Lipids; Menopause; Middle Aged; Norgestrel; Transaminases | 1977 |
Hormone therapy and affect.
Topics: Affect; Aged; Castration; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Hysterectomy; Menopause; Norgestrel; Progesterone; Psychiatric Status Rating Scales | 1979 |
Menopausal therapy and endometrial pathology.
Topics: Drug Combinations; Endometrium; Estradiol; Female; Humans; Menopause; Norethindrone; Norgestrel | 1978 |
Serum lipids during oestradiol-valerate/norgestrel treatment of menopausal women. Double-blind study of a sequential preparation.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Depression, Chemical; Drug Combinations; Estradiol; Fatty Acids, Nonesterified; Female; Glycerol; Humans; Lipids; Lipoproteins; Menopause; Middle Aged; Norgestrel; Placebos; Triglycerides; Valerates | 1975 |
[Gynecological, hematological and metabolic studies during therapy with an estrogen-gestagen combination preparation].
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Blood Cell Count; Blood Glucose; Blood Pressure; Cervix Uteri; Climacteric; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Sequential; Estradiol; Female; Hematocrit; Humans; Menopause; Middle Aged; Norgestrel; Placebos; Triglycerides; Vagina; Vaginal Smears | 1975 |
Effects of oestradiol valerate plus two different progestogens on serum lipids during post-menopausal replacement therapy.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Norgestrel; Triglycerides | 1991 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Sex Hormone-Binding Globulin | 1991 |
Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
Topics: Absorptiometry, Photon; Administration, Cutaneous; Administration, Oral; Bone Density; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Female; Femur Head; Humans; Lumbar Vertebrae; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Osteoporosis; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
Topics: Administration, Oral; Biotransformation; Estradiol; Estrogens; Estrone; Female; Half-Life; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Random Allocation; Sex Hormone-Binding Globulin | 1990 |
Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Random Allocation | 1989 |
Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Progesterone; Random Allocation | 1989 |
Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Triglycerides | 1987 |
Clinical experience with a low-dose combination of estradiol valerate and levonorgestrel. Double-blind comparative study between SH D 386 F and Cyclabil. Effects on symptoms, lipids and endometrial condition.
Topics: Adult; Cholesterol; Cholesterol, HDL; Climacteric; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Random Allocation; Triglycerides | 1986 |
[Sequence therapy with estradiol valerate-norgestrel at menopause. A double-blind investigation].
Topics: Adult; Clinical Trials as Topic; Estradiol; Female; Humans; Menopause; Menstruation Disturbances; Middle Aged; Norgestrel; Placebos | 1974 |
53 other study(ies) available for norgestrel and Menopause
Article | Year |
---|---|
Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
Topics: Adult; Aged; Cholesterol; Clonidine; Dydrogesterone; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides | 1982 |
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners; Time Factors | 1983 |
The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women.
Topics: Cholesterol; Drug Combinations; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Mestranol; Norethindrone; Norgestrel; Time Factors; Triglycerides | 1980 |
The role of estradiol dehydrogenase in mediating progestin effects on endometrium from postmenopausal women receiving estrogens and progestins.
Topics: 17-Hydroxysteroid Dehydrogenases; DNA; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Norethindrone; Norgestrel; Receptors, Estradiol; Receptors, Estrogen | 1981 |
Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy.
Topics: DNA; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners | 1982 |
Dose-dependent effects of synthetic progestins on the biochemistry of the estrogenized post-menopausal endometrium.
Topics: Cell Nucleus; DNA; Dose-Response Relationship, Drug; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Menopause; Norethindrone; Norgestrel; Progesterone Congeners; Receptors, Estradiol; Receptors, Estrogen | 1981 |
Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides.
Topics: Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Estradiol; Estriol; Estrogens; Female; Humans; Lipoproteins, HDL; Long-Term Care; Menopause; Middle Aged; Norgestrel; Triglycerides | 1983 |
Lipoprotein levels during hormone replacement therapy by vaginal ring pessaries.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Menopause; Middle Aged; Norgestrel; Pessaries | 1984 |
Effect of medroxyprogesterone acetate and d-norgestrel on plasma renin activity, antidiuretic hormone, and urinary aldosterone in postmenopausal women.
Topics: Aged; Aldosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Renin; Time Factors; Vasopressins | 1981 |
Skinfold thickness and long-term post-menopausal hormone therapy.
Topics: Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Middle Aged; Norgestrel; Skin; Skinfold Thickness; Time Factors | 1984 |
Reduction of plasma high-density lipoprotein cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment.
Topics: Cholesterol; Cholesterol, HDL; Female; Heparin; Humans; Levonorgestrel; Lipase; Lipoproteins, HDL; Liver; Menopause; Menstruation Disturbances; Middle Aged; Norgestrel; Stereoisomerism | 1981 |
The value of endometrial cell sampling in the management of post-menopausal women.
Topics: Cytodiagnosis; Dilatation and Curettage; Endometrial Hyperplasia; Endometrium; Estrogens; Female; Humans; Levonorgestrel; Menopause; Norgestrel; Polyps; Stereoisomerism; Uterine Neoplasms | 1981 |
Effects of oestradiol on sex hormone binding globulin.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Female; Humans; Levonorgestrel; Menopause; Menotropins; Menstruation; Norgestrel; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 1982 |
Hormone replacement therapy and sexuality in women.
Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hysterectomy; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Sexual Behavior | 1982 |
Effects of various types and dosages of progestogens on the postmenopausal endometrium.
Topics: DNA; Endometrium; Enzyme Induction; Estradiol Dehydrogenases; Estrogens; Female; Humans; Menopause; Mitosis; Norethindrone; Norgestrel; Progestins | 1982 |
Plasma levels of ethinyl oestradiol and norgestrel during hormone replacement therapy.
Topics: Adult; Castration; Double-Blind Method; Drug Combinations; Estradiol; Female; Humans; Menopause; Middle Aged; Norgestrel; Placebos; Time Factors | 1980 |
Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.
Topics: DNA; Dose-Response Relationship, Drug; Endometrium; Estradiol; Estradiol Congeners; Estradiol Dehydrogenases; Estrogens; Estrone; Female; Humans; Isocitrate Dehydrogenase; Menopause; Norethindrone; Norgestrel; Piperazines; Progestins; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone | 1981 |
Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
Topics: Cholesterol; Drug Administration Schedule; Estradiol; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners | 1981 |
Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women.
Topics: Aged; Apolipoproteins B; Cholesterol; Female; Humans; Lipoproteins; Menopause; Middle Aged; Norgestrel; Progestins; Triglycerides | 1993 |
Laboratory criteria for menopause in women using oral contraceptives.
Topics: Adult; Aged; Contraceptives, Oral; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Pilot Projects; Prospective Studies; Time Factors | 1996 |
[Comparative study of the action and effects of 3 estro-progestinic preparations with different composition, dosage and regimens].
Topics: Acne Vulgaris; Adolescent; Adult; Chlormadinone Acetate; Contraceptives, Oral; Drug Combinations; Ethynodiol Diacetate; Female; Headache; Hirsutism; Humans; Menopause; Menstruation Disturbances; Mestranol; Middle Aged; Norgestrel | 1975 |
An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol.
Topics: Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Menopause; Mestranol; Norethindrone; Norgestrel; Pregnancy; Transcortin | 1978 |
[Effects of several estrogenic compounds on serum corticosteroid-binding globulin (CBG) and the estrogen thresholds for increasing CBG (author's transl)].
Topics: Adult; Dose-Response Relationship, Drug; Estradiol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Menopause; Menstruation; Middle Aged; Norgestrel; Pregnancy; Transcortin | 1978 |
Pharmacokinetic and pharmacodynamic studies on oestradiol valerianate administered orally to postmenopausal women.
Topics: Administration, Oral; Adult; Aged; Estradiol; Estrone; Female; Humans; Intestinal Absorption; Menopause; Middle Aged; Norgestrel; Prostaglandins E | 1977 |
Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women.
Topics: Adolescent; Adult; Antipyrine; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Liver; Menopause; Norgestrel; Organ Size; Time Factors | 1978 |
Scanning electron microscopy of the effect of short-term hormonal therapy on postmenopausal endometrium.
Topics: Aged; Endometrium; Epithelium; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Microscopy, Electron, Scanning; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progestins; Time Factors | 1978 |
The effect of oestradiol valerate and cyclic oestradiol valerate/DL-norgestrel on calcium metabolism.
Topics: Calcium; Estradiol; Female; Humans; Hydroxyproline; Menopause; Norgestrel | 1978 |
The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.
Topics: Adolescent; Adult; Drug Combinations; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Lynestrenol; Male; Medroxyprogesterone; Megestrol; Menopause; Middle Aged; Norgestrel; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Progesterone Congeners; Protein Binding; Serum Globulins | 1975 |
[Our experience with a sequential estro-progestinic agent. Its use in disorders of the menstrual cycle and in the dysautonomic syndrome of the premenopausal period].
Topics: Adult; Estradiol; Female; Humans; Menopause; Menstruation Disturbances; Middle Aged; Norgestrel | 1976 |
Short-term changes in lipoproteins and apoproteins during cyclical oestrogen-progestogen replacement therapy.
Topics: Apoproteins; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Menopause; Middle Aged; Norgestrel; Time Factors | 1991 |
Prolonged effects of a novel, low-dosage continuous progestin-cyclic estrogen replacement program in postmenopausal women.
Topics: Blood Pressure; Bone Density; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Climacteric; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norgestrel; Triglycerides; Uterine Hemorrhage | 1992 |
Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
Topics: Adult; Anovulation; Desogestrel; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norgestrel; Norpregnenes; Ovarian Diseases; Ovulation; Progesterone; Progestins | 1991 |
A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women.
Topics: Cholesterol, HDL; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Lipase; Liver; Menopause; Middle Aged; Norgestrel; Osmolar Concentration; Regression Analysis | 1991 |
Effects of treatment with oestradiol/levonorgestrel on bone, lipoproteins and hormone status in postmenopausal women.
Topics: Administration, Intravaginal; Bone and Bones; Bone Density; Bone Resorption; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipoproteins; Menopause; Norgestrel; Pessaries | 1989 |
Are fixed-dose oestrogen/progestogen combinations ideal for all HRT users?
Topics: Cell Division; Drug Therapy, Combination; Endometrium; Estrogens; Female; Humans; Menopause; Norethindrone; Norgestrel; Retrospective Studies | 1989 |
[Estrogen-gestagen prevention and treatment of uterine hemorrhages in the premenopause].
Topics: Climacteric; Contraceptives, Oral, Combined; Drug Evaluation; Estradiol; Female; Hemostasis; Humans; Lipids; Menopause; Middle Aged; Norgestrel; Uterine Hemorrhage | 1989 |
Effects of conjugated equine oestrogens with and without the addition of cyclical norgestrel on serum and urine electrolytes, and the biochemical indices of bone metabolism and liver function.
Topics: Bone and Bones; Cyclization; Drug Administration Schedule; Drug Therapy, Combination; Electrolytes; Estrogens, Conjugated (USP); Female; Humans; Liver; Menopause; Middle Aged; Norgestrel | 1988 |
Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women.
Topics: Apolipoproteins B; Drug Combinations; Estradiol; Female; Humans; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menopause; Middle Aged; Norgestrel | 1989 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Assessment of the potency of orally administered progestins in women.
Topics: Administration, Oral; Adult; Age Factors; DNA; Dose-Response Relationship, Drug; Drug Evaluation; Dydrogesterone; Endometrium; Estradiol Dehydrogenases; Female; Glycogen; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progesterone Congeners; Reference Values | 1986 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
Ovarian function during oestrogen-progestin replacement treatment in pre-menopausal women.
Topics: Adult; Estradiol; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Menopause; Menstrual Cycle; Middle Aged; Norgestrel; Ovary; Progesterone; Stereoisomerism; Ultrasonics | 1986 |
The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Lipoproteins; Lipoproteins, VLDL; Menopause; Middle Aged; Norgestrel; Ovariectomy; Triglycerides | 1986 |
Sex steroid replacement in post-menopausal women: effects on thyroid hormone status.
Topics: Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norgestrel; Thyroid Hormones | 1987 |
Endometrial effects of a continuous percutaneous oestrogen/low dose oral progestogen regimen for climacteric complaints.
Topics: Administration, Cutaneous; Administration, Oral; Cell Division; Climacteric; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menopause; Norgestrel | 1987 |
Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women.
Topics: Administration, Oral; Bone and Bones; Cross-Sectional Studies; Estradiol; Estrogens; Female; Humans; Hydroxyapatites; Injections, Subcutaneous; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Osteoporosis; Testosterone | 1988 |
A gonadotropin and alpha-subunit suppression test for the assessment of the ectopic production of human chorionic gonadotropin and its subunits after the menopause.
Topics: Aged; Choriocarcinoma; Chorionic Gonadotropin; Chromatography, Gel; Contraceptive Agents, Female; Depression, Chemical; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Pituitary Function Tests; Pregnancy; Radioimmunoassay | 1985 |
The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Estrone; Female; Humans; Levonorgestrel; Lipids; Menopause; Middle Aged; Norgestrel | 1985 |
Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone.
Topics: Aged; Apolipoproteins A; Cholesterol, HDL; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Progesterone; Progesterone Congeners | 1985 |
Scanning electron microscopic study of the human fallopian tube. 3. The effect of midpregnancy and of various steroids.
Topics: Adult; Cilia; Contraceptives, Oral; Endometrium; Estrogens; Ethinyl Estradiol; Ethynodiol Diacetate; Fallopian Tubes; Female; Gestational Age; Humans; Megestrol; Menopause; Mestranol; Microscopy, Electron, Scanning; Middle Aged; Norgestrel; Pregnancy; Testosterone | 1973 |
Postmenopausal bleeding.
Topics: Adenocarcinoma; Adrenal Glands; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Humans; Menopause; Menstruation; Middle Aged; Norgestrel; Ovary; Precancerous Conditions; Progesterone; Uterine Hemorrhage; Uterine Neoplasms | 1974 |
The effects of oral contraceptives on glucose tolerance.
Topics: Administration, Oral; Adult; Blood Glucose; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Menopause; Mestranol; Middle Aged; Norgestrel; Obesity; Ovulation; Time Factors | 1968 |
[Daily fluctuation of the follicle-stimulating (FSH) and luteinizing (LH) hormone in the human plasma].
Topics: Acetates; Adult; Castration; Circadian Rhythm; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Menopause; Menstruation; Mestranol; Middle Aged; Norethindrone; Norgestrel; Time Factors | 1970 |